telehealth weight loss – Page 2 – Diet Business Watch

Weight Watchers Hires New International V.P.

Sept. 3, 2025 WW announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers’ business outside of the United States, driving international growth and innovation across the Company’s global footprint. “Alejandro’s international experience and commercial leadership make him uniquely suited to advance our growth outside […]

Weight Watchers Hires New International V.P. Read More »

Weight Watchers Reports Q2 2025 Results

News / John LaRosa

August 11, 2025 The company emerged from its financial reorganization process on June 24, 2025. According to Tara Comonte, CEO of Weight Watchers: “This marks the beginning of an exciting new chapter for the Company, one that’s grounded in stronger financial footing and a clear sense of opportunity. With greater flexibility to invest, we’re accelerating

Weight Watchers Reports Q2 2025 Results Read More »

Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally

News / John LaRosa

August 6, 2025 Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of U.S. tariffs, coupled with continued competition from compounded drugs sold illegally. Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and

Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally Read More »

Noom To Offer GLP-1 Microdose Plan

News / John LaRosa

August 5, 2025 Noom is not giving up in the fight to provide GLP-1 drugs, despite pressure from Novo and Eli Lilly to stop selling compounded meds. It is now offering a “micro dose” plan. This program provides access to GLP-1 medication (if prescribed by a clinician), but at a lower, “microdose” level compared to

Noom To Offer GLP-1 Microdose Plan Read More »

Medifast Reports Q2 Results – Slide Continues

News / John LaRosa

August 4, 2025 “We are working diligently to transform our business as we look to help more people achieve optimal metabolic health,” said Dan Chard, CEO of Medifast. “We’re focused on new and impactful ways to reignite coach growth and productivity through targeted initiatives that aim to enhance our offering, expand tailored client solutions, and

Medifast Reports Q2 Results – Slide Continues Read More »

Weight Watchers Expands Collaboration With Novo Nordisk

News / John LaRosa

July 2, 2025 Weight Watchers announced an expanded collaboration with Novo Nordisk, which includes increased access to authentic, FDA-approved Wegovy® (semaglutide) injection through Weight Watchers Clinic. As part of the collaboration, Weight Watchers Clinic members will benefit from a simplified prescription process via NovoCare® Pharmacy. CenterWell Pharmacy®, which serves as the dispensing pharmacy for the

Weight Watchers Expands Collaboration With Novo Nordisk Read More »

Medifast Reports First Quarter Results – Slide Continues

News / John LaRosa

April 28, 2025 According to CEO Dan Chard: “This year, we are focused on revitalizing our coach and customer base by supporting them with enhanced tools, data, and new products. Our business focus remains on reestablishing sustainable long-term growth while improving profitability.” First quarter 2025 revenue decreased 33.8% to $115.7 million from $174.7 million for the

Medifast Reports First Quarter Results – Slide Continues Read More »

Eli Lilly’s New Weight Loss Pill Shows Promise

News / John LaRosa

April 17, 2025 New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs. Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6%

Eli Lilly’s New Weight Loss Pill Shows Promise Read More »

Gyms Start Selling GLP-1 Drugs? The Bandwagon Gets More Crowded

News / John LaRosa

April 12, 2025 We noticed a post on Instagram today that pitches a company that will set up a medical weight loss program, using GLP-1 drugs for gyms. We shouldn’t be surprised. Everyone else has entered the GLP-1 gold rush, including med spas, so why not gyms as well? The company offering this “opportunity” is

Gyms Start Selling GLP-1 Drugs? The Bandwagon Gets More Crowded Read More »

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down

News / John LaRosa

March 14, 2025 On Mar. 5, a judge denied a request from the Outsourcing Facilities Association (OFA), an industry group for compounding pharmacies, to block the FDA’s attempt to stop the production of compounded tirzepatide. Generally, making copies of brand-name drugs is not legal until their patents expire. But there are exceptions: Compounding pharmacies can

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down Read More »